Walgreens Boots (NASDAQ:WBA) rose 1.6% after the drugstore chain's CEO responded to recent takeover speculation. Walgreens ...
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
Walgreens continues to discount that report ... drive long-term value indicate that the rumored sale to PE firm Sycamore Partners is less likely." Mizuho Securities USA analyst Ann Hynes, too ...
Advocate Health is shuttering 55 clinics inside Walgreens stores in Illinois and Wisconsin, effective Feb. 6.
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...